Stock data
InMed Pharmaceuticals Inc. (INM)
InMed Pharmaceuticals Inc. (INM) reported net income of -US$12.56M for fiscal 2026. The figures below come from the company's SEC filings.
Annual results
Data as of 2026-06-30
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2026 | — | — | — | -US$12.56M | — |
| 2025 | US$4.94M | US$1.71M | — | -US$8.16M | — |
| 2024 | US$4.60M | US$1.10M | — | -US$7.68M | — |
| 2023 | US$4.14M | US$1.40M | -US$7.95M | -US$7.95M | — |
| 2022 | US$1.37M | US$0.54M | -US$18.60M | -US$18.60M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$5.84M | — |
| 2026-03-31 | — | -US$2.97M | — |
| 2025-12-31 | US$0.82M | -US$2.03M | — |
| 2025-09-30 | US$1.12M | -US$1.73M | — |
| 2025-06-30 | US$1.30M | -US$1.79M | — |
| 2025-03-31 | US$1.26M | -US$2.12M | — |
| 2024-12-31 | US$1.11M | -US$2.58M | — |
| 2024-09-30 | US$1.26M | -US$1.68M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.